Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01775943
Recruitment Status : Unknown
Verified December 2013 by Young Joo Min, Ulsan University Hospital.
Recruitment status was:  Enrolling by invitation
First Posted : January 25, 2013
Last Update Posted : December 12, 2013
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Young Joo Min, Ulsan University Hospital

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2013
Estimated Study Completion Date : February 2014
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 December 11, 2014
December 18, 2014
2 December 22, 2014
January 6, 2015
3 January 14, 2015
January 15, 2015